Janna Adler
Adult Health · Brooklyn, NYNPI 1023452034
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 336 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,881, 2.7 times the $1,049 reported in 2022. Among adult health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 336 payments — averaging $25.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Madrigal Pharmaceuticals$1K
- Johnson & Johnson$1K
- Takeda Pharmaceuticals U.S.A., Inc.$633
- Bristol Myers Squibb$451
- Lilly USA, LLC$348
- plus $4K from 23 others
What the payments were for
- Food & beverage$8,43498%
- Education$2022%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 67 | $1,215 |
| Madrigal Pharmaceuticals | 36 | $1,213 |
| Johnson & Johnson | 29 | $1,034 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $633 |
| Bristol Myers Squibb | 38 | $451 |
| Lilly USA, LLC | 12 | $348 |
| AbbVie | 24 | $336 |
| Intercept Pharmaceuticals, Inc. | 10 | $322 |
| Phathom Pharmaceuticals, Inc. | 12 | $318 |
| Gilead | 4 | $273 |
| Boehringer Ingelheim | 8 | $236 |
| Ironwood Pharmaceuticals, Inc | 11 | $219 |
| QOL Medical, LLC | 11 | $219 |
| Aimmune Therapeutics, Inc. | 5 | $219 |
| Ardelyx, Inc. | 9 | $218 |
| Janssen Scientific Affairs, LLC | 3 | $196 |
| Merck | 9 | $190 |
| Intra-sana Laboratories | 1 | $150 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Amgen | 1 | $124 |
| Sanofi-aventis U.S. LLC | 1 | $119 |
| Pfizer | 7 | $115 |
| Regeneron Healthcare Solutions, Inc. | 6 | $100 |
| Ipsen Biopharmaceuticals, Inc | 3 | $64 |
| Exact Sciences | 2 | $49 |
| Sanofi | 2 | $45 |
| Braintree Laboratories, Inc. | 2 | $45 |
| Celltrion USA Inc. | 2 | $38 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,636 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 26 | $22,520 |
| Sucralfate | 45 | $2,741 |
| Famotidine | 160 | $2,618 |
| Omeprazole | 150 | $2,058 |
| Dicyclomine Hcl | 32 | $604 |
| Pantoprazole Sodium | 53 | $470 |
| Esomeprazole Magnesium | 11 | $270 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $336 | $22,52026 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,828 adult health providers in New York.
Other adult health in Brooklyn
- Huiwen YingBrooklyn$17K
- Joyce YeungBrooklyn$15K
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Mary CiechoskiBuffalo$200K
- Jennifer FioriniGlens Falls$151K
- Katelyn McCormackAmherst$131K
- Maria Gigante-BaggettEast Syracuse$92K
- Jane PattersonRochester$66K
- Alyson HartyNew York$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.